Oude Elferink, R.P.J.

patient orlistat orlistat treatment treatment pruritu serum level concentration plasma plasma ucb concentrations disease effect cholestatic plasma ucb levels activity figure control excretion cn patients trial phototherapy sample plasma ucb concentration cholestatic patients atx activity –liver pancreas study signi liver cholestasi autotaxin side effects biliary signi ficantly blood netherland receptor increase decrease lysophosphatidic bilirubin cn disease lysophosphatidic acid intake unconjugated hyperbilirubinemia factor center ␮- opioid activity phenobarbital period lipid intensity university gunn rats value cholestatic disorders opioid intrahepatic cholestasis histamine substance correlation body weight study details tract biliary cirrhosis pruritic patients method protein 37° c serum samples unconjugated gastroenterology responder –liver placebo pancreas pruritic tryptase analysis sinaasappel m